ICG 24h Prior to Operative Treatment of Orthopaedic Infection

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

March 9, 2023

Study Completion Date

March 9, 2024

Conditions
Trauma InjuryBone Infection
Interventions
PROCEDURE

imaging 24 hours following intravenous administration of ICG

Patients will be administered a single, FDA approved, ICG, 2.5-5mg/kg dose 24 hours prior to surgery. ICG fluorescence images will be acquired By a FDA approved surgical imaging device prior to surgical debridement. The wound will be irrigated as per standard procedure and another ICG fluorescence image will be acquired. The need for repeat debridement or tissue cultures will be left up to the treating surgeon.

Trial Locations (1)

03766

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04927637 - ICG 24h Prior to Operative Treatment of Orthopaedic Infection | Biotech Hunter | Biotech Hunter